 | • レポートコード：MRC2-11QY06887 • 出版社/出版日：QYResearch / 2020年11月20日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、114ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥561,600 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥842,400 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,123,200 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料はグリコーゲンシンターゼキナーゼ3ベータのグローバル市場について調査・分析したレポートです。種類別（AP-001、AP-1、DM-204、Neu-120、その他）市場規模、用途別（筋骨格系障害、肺がん、ジスキネジア、メンケス病、その他）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別グリコーゲンシンターゼキナーゼ3ベータの競争状況、市場シェア ・世界のグリコーゲンシンターゼキナーゼ3ベータ市場：種類別市場規模 2015年-2020年（AP-001、AP-1、DM-204、Neu-120、その他） ・世界のグリコーゲンシンターゼキナーゼ3ベータ市場：種類別市場規模予測 2021年-2026年（AP-001、AP-1、DM-204、Neu-120、その他） ・世界のグリコーゲンシンターゼキナーゼ3ベータ市場：用途別市場規模 2015年-2020年（筋骨格系障害、肺がん、ジスキネジア、メンケス病、その他） ・世界のグリコーゲンシンターゼキナーゼ3ベータ市場：用途別市場規模予測 2021年-2026年（筋骨格系障害、肺がん、ジスキネジア、メンケス病、その他） ・北米のグリコーゲンシンターゼキナーゼ3ベータ市場分析：米国、カナダ ・ヨーロッパのグリコーゲンシンターゼキナーゼ3ベータ市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアのグリコーゲンシンターゼキナーゼ3ベータ市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米のグリコーゲンシンターゼキナーゼ3ベータ市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカのグリコーゲンシンターゼキナーゼ3ベータ市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Mitsubishi Tanabe Pharma Corp、Neurim Pharmaceuticals Ltd、Actuate Therapeutics Inc、DiaMedica Therapeutics Inc、Angelini Group、Jeil Pharmaceutical Co Ltd、AMO Pharma Ltd ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Market Analysis and Insights: Global Glycogen Synthase Kinase 3 Beta Market
The global Glycogen Synthase Kinase 3 Beta market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026.
Global Glycogen Synthase Kinase 3 Beta Scope and Market Size
Glycogen Synthase Kinase 3 Beta market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Glycogen Synthase Kinase 3 Beta market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Glycogen Synthase Kinase 3 Beta market is segmented into
AP-001
AP-1
DM-204
Neu-120
Others
Segment by Application, the Glycogen Synthase Kinase 3 Beta market is segmented into
Musculoskeletal Disorder
Lung Cancer
Dyskinesia
Menkes Disease
Others
Regional and Country-level Analysis
The Glycogen Synthase Kinase 3 Beta market is analysed and market size information is provided by regions (countries).
The key regions covered in the Glycogen Synthase Kinase 3 Beta market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Glycogen Synthase Kinase 3 Beta Market Share Analysis
Glycogen Synthase Kinase 3 Beta market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Glycogen Synthase Kinase 3 Beta business, the date to enter into the Glycogen Synthase Kinase 3 Beta market, Glycogen Synthase Kinase 3 Beta product introduction, recent developments, etc.
The major vendors covered:
Mitsubishi Tanabe Pharma Corp
Neurim Pharmaceuticals Ltd
Actuate Therapeutics Inc
DiaMedica Therapeutics Inc
Angelini Group
Jeil Pharmaceutical Co Ltd
AMO Pharma Ltd
…
1 Study Coverage
1.1 Glycogen Synthase Kinase 3 Beta Product Introduction
1.2 Market Segments
1.3 Key Glycogen Synthase Kinase 3 Beta Manufacturers Covered: Ranking by Revenue
1.4 Market by Type
1.4.1 Global Glycogen Synthase Kinase 3 Beta Market Size Growth Rate by Type
1.4.2 AP-001
1.4.3 AP-1
1.4.4 DM-204
1.4.5 Neu-120
1.4.6 Others
1.5 Market by Application
1.5.1 Global Glycogen Synthase Kinase 3 Beta Market Size Growth Rate by Application
1.5.2 Musculoskeletal Disorder
1.5.3 Lung Cancer
1.5.4 Dyskinesia
1.5.5 Menkes Disease
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered
2 Executive Summary
2.1 Global Glycogen Synthase Kinase 3 Beta Market Size, Estimates and Forecasts
2.1.1 Global Glycogen Synthase Kinase 3 Beta Revenue 2015-2026
2.1.2 Global Glycogen Synthase Kinase 3 Beta Sales 2015-2026
2.2 Global Glycogen Synthase Kinase 3 Beta, Market Size by Producing Regions: 2015 VS 2020 VS 2026
2.2.1 Global Glycogen Synthase Kinase 3 Beta Retrospective Market Scenario in Sales by Region: 2015-2020
2.2.2 Global Glycogen Synthase Kinase 3 Beta Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Glycogen Synthase Kinase 3 Beta Competitor Landscape by Players
3.1 Glycogen Synthase Kinase 3 Beta Sales by Manufacturers
3.1.1 Glycogen Synthase Kinase 3 Beta Sales by Manufacturers (2015-2020)
3.1.2 Glycogen Synthase Kinase 3 Beta Sales Market Share by Manufacturers (2015-2020)
3.2 Glycogen Synthase Kinase 3 Beta Revenue by Manufacturers
3.2.1 Glycogen Synthase Kinase 3 Beta Revenue by Manufacturers (2015-2020)
3.2.2 Glycogen Synthase Kinase 3 Beta Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Glycogen Synthase Kinase 3 Beta Market Concentration Ratio (CR5 and HHI) (2015-2020)
3.2.4 Global Top 10 and Top 5 Companies by Glycogen Synthase Kinase 3 Beta Revenue in 2019
3.2.5 Global Glycogen Synthase Kinase 3 Beta Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Glycogen Synthase Kinase 3 Beta Price by Manufacturers
3.4 Glycogen Synthase Kinase 3 Beta Manufacturing Base Distribution, Product Types
3.4.1 Glycogen Synthase Kinase 3 Beta Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Glycogen Synthase Kinase 3 Beta Product Type
3.4.3 Date of International Manufacturers Enter into Glycogen Synthase Kinase 3 Beta Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Glycogen Synthase Kinase 3 Beta Market Size by Type (2015-2020)
4.1.1 Global Glycogen Synthase Kinase 3 Beta Sales by Type (2015-2020)
4.1.2 Global Glycogen Synthase Kinase 3 Beta Revenue by Type (2015-2020)
4.1.3 Glycogen Synthase Kinase 3 Beta Average Selling Price (ASP) by Type (2015-2026)
4.2 Global Glycogen Synthase Kinase 3 Beta Market Size Forecast by Type (2021-2026)
4.2.1 Global Glycogen Synthase Kinase 3 Beta Sales Forecast by Type (2021-2026)
4.2.2 Global Glycogen Synthase Kinase 3 Beta Revenue Forecast by Type (2021-2026)
4.2.3 Glycogen Synthase Kinase 3 Beta Average Selling Price (ASP) Forecast by Type (2021-2026)
4.3 Global Glycogen Synthase Kinase 3 Beta Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
5.1 Global Glycogen Synthase Kinase 3 Beta Market Size by Application (2015-2020)
5.1.1 Global Glycogen Synthase Kinase 3 Beta Sales by Application (2015-2020)
5.1.2 Global Glycogen Synthase Kinase 3 Beta Revenue by Application (2015-2020)
5.1.3 Glycogen Synthase Kinase 3 Beta Price by Application (2015-2020)
5.2 Glycogen Synthase Kinase 3 Beta Market Size Forecast by Application (2021-2026)
5.2.1 Global Glycogen Synthase Kinase 3 Beta Sales Forecast by Application (2021-2026)
5.2.2 Global Glycogen Synthase Kinase 3 Beta Revenue Forecast by Application (2021-2026)
5.2.3 Global Glycogen Synthase Kinase 3 Beta Price Forecast by Application (2021-2026)
6 North America
6.1 North America Glycogen Synthase Kinase 3 Beta by Country
6.1.1 North America Glycogen Synthase Kinase 3 Beta Sales by Country
6.1.2 North America Glycogen Synthase Kinase 3 Beta Revenue by Country
6.1.3 U.S.
6.1.4 Canada
6.2 North America Glycogen Synthase Kinase 3 Beta Market Facts & Figures by Type
6.3 North America Glycogen Synthase Kinase 3 Beta Market Facts & Figures by Application
7 Europe
7.1 Europe Glycogen Synthase Kinase 3 Beta by Country
7.1.1 Europe Glycogen Synthase Kinase 3 Beta Sales by Country
7.1.2 Europe Glycogen Synthase Kinase 3 Beta Revenue by Country
7.1.3 Germany
7.1.4 France
7.1.5 U.K.
7.1.6 Italy
7.1.7 Russia
7.2 Europe Glycogen Synthase Kinase 3 Beta Market Facts & Figures by Type
7.3 Europe Glycogen Synthase Kinase 3 Beta Market Facts & Figures by Application
8 Asia Pacific
8.1 Asia Pacific Glycogen Synthase Kinase 3 Beta by Region
8.1.1 Asia Pacific Glycogen Synthase Kinase 3 Beta Sales by Region
8.1.2 Asia Pacific Glycogen Synthase Kinase 3 Beta Revenue by Region
8.1.3 China
8.1.4 Japan
8.1.5 South Korea
8.1.6 India
8.1.7 Australia
8.1.8 Taiwan
8.1.9 Indonesia
8.1.10 Thailand
8.1.11 Malaysia
8.1.12 Philippines
8.1.13 Vietnam
8.2 Asia Pacific Glycogen Synthase Kinase 3 Beta Market Facts & Figures by Type
8.3 Asia Pacific Glycogen Synthase Kinase 3 Beta Market Facts & Figures by Application
9 Latin America
9.1 Latin America Glycogen Synthase Kinase 3 Beta by Country
9.1.1 Latin America Glycogen Synthase Kinase 3 Beta Sales by Country
9.1.2 Latin America Glycogen Synthase Kinase 3 Beta Revenue by Country
9.1.3 Mexico
9.1.4 Brazil
9.1.5 Argentina
9.2 Central & South America Glycogen Synthase Kinase 3 Beta Market Facts & Figures by Type
9.3 Central & South America Glycogen Synthase Kinase 3 Beta Market Facts & Figures by Application
10 Middle East and Africa
10.1 Middle East and Africa Glycogen Synthase Kinase 3 Beta by Country
10.1.1 Middle East and Africa Glycogen Synthase Kinase 3 Beta Sales by Country
10.1.2 Middle East and Africa Glycogen Synthase Kinase 3 Beta Revenue by Country
10.1.3 Turkey
10.1.4 Saudi Arabia
10.1.5 U.A.E
10.2 Middle East and Africa Glycogen Synthase Kinase 3 Beta Market Facts & Figures by Type
10.3 Middle East and Africa Glycogen Synthase Kinase 3 Beta Market Facts & Figures by Application
11 Company Profiles
11.1 Mitsubishi Tanabe Pharma Corp
11.1.1 Mitsubishi Tanabe Pharma Corp Corporation Information
11.1.2 Mitsubishi Tanabe Pharma Corp Description and Business Overview
11.1.3 Mitsubishi Tanabe Pharma Corp Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Mitsubishi Tanabe Pharma Corp Glycogen Synthase Kinase 3 Beta Products Offered
11.1.5 Mitsubishi Tanabe Pharma Corp Related Developments
11.2 Neurim Pharmaceuticals Ltd
11.2.1 Neurim Pharmaceuticals Ltd Corporation Information
11.2.2 Neurim Pharmaceuticals Ltd Description and Business Overview
11.2.3 Neurim Pharmaceuticals Ltd Sales, Revenue and Gross Margin (2015-2020)
11.2.4 Neurim Pharmaceuticals Ltd Glycogen Synthase Kinase 3 Beta Products Offered
11.2.5 Neurim Pharmaceuticals Ltd Related Developments
11.3 Actuate Therapeutics Inc
11.3.1 Actuate Therapeutics Inc Corporation Information
11.3.2 Actuate Therapeutics Inc Description and Business Overview
11.3.3 Actuate Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.3.4 Actuate Therapeutics Inc Glycogen Synthase Kinase 3 Beta Products Offered
11.3.5 Actuate Therapeutics Inc Related Developments
11.4 DiaMedica Therapeutics Inc
11.4.1 DiaMedica Therapeutics Inc Corporation Information
11.4.2 DiaMedica Therapeutics Inc Description and Business Overview
11.4.3 DiaMedica Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
11.4.4 DiaMedica Therapeutics Inc Glycogen Synthase Kinase 3 Beta Products Offered
11.4.5 DiaMedica Therapeutics Inc Related Developments
11.5 Angelini Group
11.5.1 Angelini Group Corporation Information
11.5.2 Angelini Group Description and Business Overview
11.5.3 Angelini Group Sales, Revenue and Gross Margin (2015-2020)
11.5.4 Angelini Group Glycogen Synthase Kinase 3 Beta Products Offered
11.5.5 Angelini Group Related Developments
11.6 Jeil Pharmaceutical Co Ltd
11.6.1 Jeil Pharmaceutical Co Ltd Corporation Information
11.6.2 Jeil Pharmaceutical Co Ltd Description and Business Overview
11.6.3 Jeil Pharmaceutical Co Ltd Sales, Revenue and Gross Margin (2015-2020)
11.6.4 Jeil Pharmaceutical Co Ltd Glycogen Synthase Kinase 3 Beta Products Offered
11.6.5 Jeil Pharmaceutical Co Ltd Related Developments
11.7 AMO Pharma Ltd
11.7.1 AMO Pharma Ltd Corporation Information
11.7.2 AMO Pharma Ltd Description and Business Overview
11.7.3 AMO Pharma Ltd Sales, Revenue and Gross Margin (2015-2020)
11.7.4 AMO Pharma Ltd Glycogen Synthase Kinase 3 Beta Products Offered
11.7.5 AMO Pharma Ltd Related Developments
11.1 Mitsubishi Tanabe Pharma Corp
11.1.1 Mitsubishi Tanabe Pharma Corp Corporation Information
11.1.2 Mitsubishi Tanabe Pharma Corp Description and Business Overview
11.1.3 Mitsubishi Tanabe Pharma Corp Sales, Revenue and Gross Margin (2015-2020)
11.1.4 Mitsubishi Tanabe Pharma Corp Glycogen Synthase Kinase 3 Beta Products Offered
11.1.5 Mitsubishi Tanabe Pharma Corp Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
12.1 Glycogen Synthase Kinase 3 Beta Market Estimates and Projections by Region
12.1.1 Global Glycogen Synthase Kinase 3 Beta Sales Forecast by Regions 2021-2026
12.1.2 Global Glycogen Synthase Kinase 3 Beta Revenue Forecast by Regions 2021-2026
12.2 North America Glycogen Synthase Kinase 3 Beta Market Size Forecast (2021-2026)
12.2.1 North America: Glycogen Synthase Kinase 3 Beta Sales Forecast (2021-2026)
12.2.2 North America: Glycogen Synthase Kinase 3 Beta Revenue Forecast (2021-2026)
12.2.3 North America: Glycogen Synthase Kinase 3 Beta Market Size Forecast by Country (2021-2026)
12.3 Europe Glycogen Synthase Kinase 3 Beta Market Size Forecast (2021-2026)
12.3.1 Europe: Glycogen Synthase Kinase 3 Beta Sales Forecast (2021-2026)
12.3.2 Europe: Glycogen Synthase Kinase 3 Beta Revenue Forecast (2021-2026)
12.3.3 Europe: Glycogen Synthase Kinase 3 Beta Market Size Forecast by Country (2021-2026)
12.4 Asia Pacific Glycogen Synthase Kinase 3 Beta Market Size Forecast (2021-2026)
12.4.1 Asia Pacific: Glycogen Synthase Kinase 3 Beta Sales Forecast (2021-2026)
12.4.2 Asia Pacific: Glycogen Synthase Kinase 3 Beta Revenue Forecast (2021-2026)
12.4.3 Asia Pacific: Glycogen Synthase Kinase 3 Beta Market Size Forecast by Region (2021-2026)
12.5 Latin America Glycogen Synthase Kinase 3 Beta Market Size Forecast (2021-2026)
12.5.1 Latin America: Glycogen Synthase Kinase 3 Beta Sales Forecast (2021-2026)
12.5.2 Latin America: Glycogen Synthase Kinase 3 Beta Revenue Forecast (2021-2026)
12.5.3 Latin America: Glycogen Synthase Kinase 3 Beta Market Size Forecast by Country (2021-2026)
12.6 Middle East and Africa Glycogen Synthase Kinase 3 Beta Market Size Forecast (2021-2026)
12.6.1 Middle East and Africa: Glycogen Synthase Kinase 3 Beta Sales Forecast (2021-2026)
12.6.2 Middle East and Africa: Glycogen Synthase Kinase 3 Beta Revenue Forecast (2021-2026)
12.6.3 Middle East and Africa: Glycogen Synthase Kinase 3 Beta Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Porter’s Five Forces Analysis
13.5 Primary Interviews with Key Glycogen Synthase Kinase 3 Beta Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Glycogen Synthase Kinase 3 Beta Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
Table 1. Glycogen Synthase Kinase 3 Beta Market Segments
Table 2. Ranking of Global Top Glycogen Synthase Kinase 3 Beta Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Glycogen Synthase Kinase 3 Beta Market Size Growth Rate by Type 2020-2026 (K Pcs) & (US$ Million)
Table 4. Major Manufacturers of AP-001
Table 5. Major Manufacturers of AP-1
Table 6. Major Manufacturers of DM-204
Table 7. Major Manufacturers of Neu-120
Table 8. Major Manufacturers of Others
Table 9. Global Glycogen Synthase Kinase 3 Beta Market Size Growth Rate by Application 2020-2026 (K Pcs)
Table 10. Global Glycogen Synthase Kinase 3 Beta Market Size by Region (K Pcs) & (US$ Million): 2020 VS 2026
Table 11. Global Glycogen Synthase Kinase 3 Beta Sales by Regions 2015-2020 (K Pcs)
Table 12. Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Regions (2015-2020)
Table 13. Global Glycogen Synthase Kinase 3 Beta Revenue by Regions 2015-2020 (US$ Million)
Table 14. Global Glycogen Synthase Kinase 3 Beta Sales by Manufacturers (2015-2020) (K Pcs)
Table 15. Global Glycogen Synthase Kinase 3 Beta Sales Share by Manufacturers (2015-2020)
Table 16. Global Glycogen Synthase Kinase 3 Beta Manufacturers Market Concentration Ratio (CR5 and HHI) (2015-2020)
Table 17. Global Glycogen Synthase Kinase 3 Beta by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Glycogen Synthase Kinase 3 Beta as of 2019)
Table 18. Glycogen Synthase Kinase 3 Beta Revenue by Manufacturers (2015-2020) (US$ Million)
Table 19. Glycogen Synthase Kinase 3 Beta Revenue Share by Manufacturers (2015-2020)
Table 20. Key Manufacturers Glycogen Synthase Kinase 3 Beta Price (2015-2020) (USD/Pcs)
Table 21. Glycogen Synthase Kinase 3 Beta Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers Glycogen Synthase Kinase 3 Beta Product Type
Table 23. Date of International Manufacturers Enter into Glycogen Synthase Kinase 3 Beta Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global Glycogen Synthase Kinase 3 Beta Sales by Type (2015-2020) (K Pcs)
Table 26. Global Glycogen Synthase Kinase 3 Beta Sales Share by Type (2015-2020)
Table 27. Global Glycogen Synthase Kinase 3 Beta Revenue by Type (2015-2020) (US$ Million)
Table 28. Global Glycogen Synthase Kinase 3 Beta Revenue Share by Type (2015-2020)
Table 29. Glycogen Synthase Kinase 3 Beta Average Selling Price (ASP) by Type 2015-2020 (USD/Pcs)
Table 30. Global Glycogen Synthase Kinase 3 Beta Sales by Application (2015-2020) (K Pcs)
Table 31. Global Glycogen Synthase Kinase 3 Beta Sales Share by Application (2015-2020)
Table 32. North America Glycogen Synthase Kinase 3 Beta Sales by Country (2015-2020) (K Pcs)
Table 33. North America Glycogen Synthase Kinase 3 Beta Sales Market Share by Country (2015-2020)
Table 34. North America Glycogen Synthase Kinase 3 Beta Revenue by Country (2015-2020) (US$ Million)
Table 35. North America Glycogen Synthase Kinase 3 Beta Revenue Market Share by Country (2015-2020)
Table 36. North America Glycogen Synthase Kinase 3 Beta Sales by Type (2015-2020) (K Pcs)
Table 37. North America Glycogen Synthase Kinase 3 Beta Sales Market Share by Type (2015-2020)
Table 38. North America Glycogen Synthase Kinase 3 Beta Sales by Application (2015-2020) (K Pcs)
Table 39. North America Glycogen Synthase Kinase 3 Beta Sales Market Share by Application (2015-2020)
Table 40. Europe Glycogen Synthase Kinase 3 Beta Sales by Country (2015-2020) (K Pcs)
Table 41. Europe Glycogen Synthase Kinase 3 Beta Sales Market Share by Country (2015-2020)
Table 42. Europe Glycogen Synthase Kinase 3 Beta Revenue by Country (2015-2020) (US$ Million)
Table 43. Europe Glycogen Synthase Kinase 3 Beta Revenue Market Share by Country (2015-2020)
Table 44. Europe Glycogen Synthase Kinase 3 Beta Sales by Type (2015-2020) (K Pcs)
Table 45. Europe Glycogen Synthase Kinase 3 Beta Sales Market Share by Type (2015-2020)
Table 46. Europe Glycogen Synthase Kinase 3 Beta Sales by Application (2015-2020) (K Pcs)
Table 47. Europe Glycogen Synthase Kinase 3 Beta Sales Market Share by Application (2015-2020)
Table 48. Asia Pacific Glycogen Synthase Kinase 3 Beta Sales by Region (2015-2020) (K Pcs)
Table 49. Asia Pacific Glycogen Synthase Kinase 3 Beta Sales Market Share by Region (2015-2020)
Table 50. Asia Pacific Glycogen Synthase Kinase 3 Beta Revenue by Region (2015-2020) (US$ Million)
Table 51. Asia Pacific Glycogen Synthase Kinase 3 Beta Revenue Market Share by Region (2015-2020)
Table 52. Asia Pacific Glycogen Synthase Kinase 3 Beta Sales by Type (2015-2020) (K Pcs)
Table 53. Asia Pacific Glycogen Synthase Kinase 3 Beta Sales Market Share by Type (2015-2020)
Table 54. Asia Pacific Glycogen Synthase Kinase 3 Beta Sales by Application (2015-2020) (K Pcs)
Table 55. Asia Pacific Glycogen Synthase Kinase 3 Beta Sales Market Share by Application (2015-2020)
Table 56. Latin America Glycogen Synthase Kinase 3 Beta Sales by Country (2015-2020) (K Pcs)
Table 57. Latin America Glycogen Synthase Kinase 3 Beta Sales Market Share by Country (2015-2020)
Table 58. Latin Americaa Glycogen Synthase Kinase 3 Beta Revenue by Country (2015-2020) (US$ Million)
Table 59. Latin America Glycogen Synthase Kinase 3 Beta Revenue Market Share by Country (2015-2020)
Table 60. Latin America Glycogen Synthase Kinase 3 Beta Sales by Type (2015-2020) (K Pcs)
Table 61. Latin America Glycogen Synthase Kinase 3 Beta Sales Market Share by Type (2015-2020)
Table 62. Latin America Glycogen Synthase Kinase 3 Beta Sales by Application (2015-2020) (K Pcs)
Table 63. Latin America Glycogen Synthase Kinase 3 Beta Sales Market Share by Application (2015-2020)
Table 64. Middle East and Africa Glycogen Synthase Kinase 3 Beta Sales by Country (2015-2020) (K Pcs)
Table 65. Middle East and Africa Glycogen Synthase Kinase 3 Beta Sales Market Share by Country (2015-2020)
Table 66. Middle East and Africa Glycogen Synthase Kinase 3 Beta Revenue by Country (2015-2020) (US$ Million)
Table 67. Middle East and Africa Glycogen Synthase Kinase 3 Beta Revenue Market Share by Country (2015-2020)
Table 68. Middle East and Africa Glycogen Synthase Kinase 3 Beta Sales by Type (2015-2020) (K Pcs)
Table 69. Middle East and Africa Glycogen Synthase Kinase 3 Beta Sales Market Share by Type (2015-2020)
Table 70. Middle East and Africa Glycogen Synthase Kinase 3 Beta Sales by Application (2015-2020) (K Pcs)
Table 71. Middle East and Africa Glycogen Synthase Kinase 3 Beta Sales Market Share by Application (2015-2020)
Table 72. Mitsubishi Tanabe Pharma Corp Corporation Information
Table 73. Mitsubishi Tanabe Pharma Corp Description and Major Businesses
Table 74. Mitsubishi Tanabe Pharma Corp Glycogen Synthase Kinase 3 Beta Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 75. Mitsubishi Tanabe Pharma Corp Product
Table 76. Mitsubishi Tanabe Pharma Corp Recent Development
Table 77. Neurim Pharmaceuticals Ltd Corporation Information
Table 78. Neurim Pharmaceuticals Ltd Description and Major Businesses
Table 79. Neurim Pharmaceuticals Ltd Glycogen Synthase Kinase 3 Beta Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 80. Neurim Pharmaceuticals Ltd Product
Table 81. Neurim Pharmaceuticals Ltd Recent Development
Table 82. Actuate Therapeutics Inc Corporation Information
Table 83. Actuate Therapeutics Inc Description and Major Businesses
Table 84. Actuate Therapeutics Inc Glycogen Synthase Kinase 3 Beta Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 85. Actuate Therapeutics Inc Product
Table 86. Actuate Therapeutics Inc Recent Development
Table 87. DiaMedica Therapeutics Inc Corporation Information
Table 88. DiaMedica Therapeutics Inc Description and Major Businesses
Table 89. DiaMedica Therapeutics Inc Glycogen Synthase Kinase 3 Beta Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 90. DiaMedica Therapeutics Inc Product
Table 91. DiaMedica Therapeutics Inc Recent Development
Table 92. Angelini Group Corporation Information
Table 93. Angelini Group Description and Major Businesses
Table 94. Angelini Group Glycogen Synthase Kinase 3 Beta Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 95. Angelini Group Product
Table 96. Angelini Group Recent Development
Table 97. Jeil Pharmaceutical Co Ltd Corporation Information
Table 98. Jeil Pharmaceutical Co Ltd Description and Major Businesses
Table 99. Jeil Pharmaceutical Co Ltd Glycogen Synthase Kinase 3 Beta Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 100. Jeil Pharmaceutical Co Ltd Product
Table 101. Jeil Pharmaceutical Co Ltd Recent Development
Table 102. AMO Pharma Ltd Corporation Information
Table 103. AMO Pharma Ltd Description and Major Businesses
Table 104. AMO Pharma Ltd Glycogen Synthase Kinase 3 Beta Production (K Pcs), Revenue (US$ Million), Price (USD/Pcs) and Gross Margin (2015-2020)
Table 105. AMO Pharma Ltd Product
Table 106. AMO Pharma Ltd Recent Development
Table 107. Global Glycogen Synthase Kinase 3 Beta Sales Forecast by Regions (2021-2026) (K Pcs)
Table 108. Global Glycogen Synthase Kinase 3 Beta Sales Market Share Forecast by Regions (2021-2026)
Table 109. Global Glycogen Synthase Kinase 3 Beta Revenue Forecast by Regions (2021-2026) (US$ Million)
Table 110. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share Forecast by Regions (2021-2026)
Table 111. North America: Glycogen Synthase Kinase 3 Beta Sales Forecast by Country (2021-2026) (K Pcs)
Table 112. North America: Glycogen Synthase Kinase 3 Beta Revenue Forecast by Country (2021-2026) (US$ Million)
Table 113. Europe: Glycogen Synthase Kinase 3 Beta Sales Forecast by Country (2021-2026) (K Pcs)
Table 114. Europe: Glycogen Synthase Kinase 3 Beta Revenue Forecast by Country (2021-2026) (US$ Million)
Table 115. Asia Pacific: Glycogen Synthase Kinase 3 Beta Sales Forecast by Region (2021-2026) (K Pcs)
Table 116. Asia Pacific: Glycogen Synthase Kinase 3 Beta Revenue Forecast by Region (2021-2026) (US$ Million)
Table 117. Latin America: Glycogen Synthase Kinase 3 Beta Sales Forecast by Country (2021-2026) (K Pcs)
Table 118. Latin America: Glycogen Synthase Kinase 3 Beta Revenue Forecast by Country (2021-2026) (US$ Million)
Table 119. Middle East and Africa: Glycogen Synthase Kinase 3 Beta Sales Forecast by Country (2021-2026) (K Pcs)
Table 120. Middle East and Africa: Glycogen Synthase Kinase 3 Beta Revenue Forecast by Country (2021-2026) (US$ Million)
Table 121. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 122. Key Challenges
Table 123. Market Risks
Table 124. Main Points Interviewed from Key Glycogen Synthase Kinase 3 Beta Players
Table 125. Glycogen Synthase Kinase 3 Beta Customers List
Table 126. Glycogen Synthase Kinase 3 Beta Distributors List
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Glycogen Synthase Kinase 3 Beta Product Picture
Figure 2. Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Type in 2020 & 2026
Figure 3. AP-001 Product Picture
Figure 4. AP-1 Product Picture
Figure 5. DM-204 Product Picture
Figure 6. Neu-120 Product Picture
Figure 7. Others Product Picture
Figure 8. Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Application in 2020 & 2026
Figure 9. Musculoskeletal Disorder
Figure 10. Lung Cancer
Figure 11. Dyskinesia
Figure 12. Menkes Disease
Figure 13. Others
Figure 14. Glycogen Synthase Kinase 3 Beta Report Years Considered
Figure 15. Global Glycogen Synthase Kinase 3 Beta Market Size 2015-2026 (US$ Million)
Figure 16. Global Glycogen Synthase Kinase 3 Beta Sales 2015-2026 (K Pcs)
Figure 17. Global Glycogen Synthase Kinase 3 Beta Market Size Market Share by Region: 2020 Versus 2026
Figure 18. Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Region (2015-2020)
Figure 19. Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Region in 2019
Figure 20. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Region (2015-2020)
Figure 21. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Region in 2019
Figure 22. Global Glycogen Synthase Kinase 3 Beta Sales Share by Manufacturer in 2019
Figure 23. The Top 10 and 5 Players Market Share by Glycogen Synthase Kinase 3 Beta Revenue in 2019
Figure 24. Glycogen Synthase Kinase 3 Beta Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 25. Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Type (2015-2020)
Figure 26. Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Type in 2019
Figure 27. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Type (2015-2020)
Figure 28. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Type in 2019
Figure 29. Global Glycogen Synthase Kinase 3 Beta Market Share by Price Range (2015-2020)
Figure 30. Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Application (2015-2020)
Figure 31. Global Glycogen Synthase Kinase 3 Beta Sales Market Share by Application in 2019
Figure 32. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Application (2015-2020)
Figure 33. Global Glycogen Synthase Kinase 3 Beta Revenue Market Share by Application in 2019
Figure 34. North America Glycogen Synthase Kinase 3 Beta Sales Growth Rate 2015-2020 (K Pcs)
Figure 35. North America Glycogen Synthase Kinase 3 Beta Revenue Growth Rate 2015-2020 (US$ Million)
Figure 36. North America Glycogen Synthase Kinase 3 Beta Sales Market Share by Country in 2019
Figure 37. North America Glycogen Synthase Kinase 3 Beta Revenue Market Share by Country in 2019
Figure 38. U.S. Glycogen Synthase Kinase 3 Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 39. U.S. Glycogen Synthase Kinase 3 Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 40. Canada Glycogen Synthase Kinase 3 Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 41. Canada Glycogen Synthase Kinase 3 Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. North America Glycogen Synthase Kinase 3 Beta Market Share by Type in 2019
Figure 43. North America Glycogen Synthase Kinase 3 Beta Market Share by Application in 2019
Figure 44. Europe Glycogen Synthase Kinase 3 Beta Sales Growth Rate 2015-2020 (K Pcs)
Figure 45. Europe Glycogen Synthase Kinase 3 Beta Revenue Growth Rate 2015-2020 (US$ Million)
Figure 46. Europe Glycogen Synthase Kinase 3 Beta Sales Market Share by Country in 2019
Figure 47. Europe Glycogen Synthase Kinase 3 Beta Revenue Market Share by Country in 2019
Figure 48. Germany Glycogen Synthase Kinase 3 Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 49. Germany Glycogen Synthase Kinase 3 Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. France Glycogen Synthase Kinase 3 Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 51. France Glycogen Synthase Kinase 3 Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. U.K. Glycogen Synthase Kinase 3 Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 53. U.K. Glycogen Synthase Kinase 3 Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Italy Glycogen Synthase Kinase 3 Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 55. Italy Glycogen Synthase Kinase 3 Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Russia Glycogen Synthase Kinase 3 Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 57. Russia Glycogen Synthase Kinase 3 Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Europe Glycogen Synthase Kinase 3 Beta Market Share by Type in 2019
Figure 59. Europe Glycogen Synthase Kinase 3 Beta Market Share by Application in 2019
Figure 60. Asia Pacific Glycogen Synthase Kinase 3 Beta Sales Growth Rate 2015-2020 (K Pcs)
Figure 61. Asia Pacific Glycogen Synthase Kinase 3 Beta Revenue Growth Rate 2015-2020 (US$ Million)
Figure 62. Asia Pacific Glycogen Synthase Kinase 3 Beta Sales Market Share by Region in 2019
Figure 63. Asia Pacific Glycogen Synthase Kinase 3 Beta Revenue Market Share by Region in 2019
Figure 64. China Glycogen Synthase Kinase 3 Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 65. China Glycogen Synthase Kinase 3 Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Japan Glycogen Synthase Kinase 3 Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 67. Japan Glycogen Synthase Kinase 3 Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. South Korea Glycogen Synthase Kinase 3 Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 69. South Korea Glycogen Synthase Kinase 3 Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. India Glycogen Synthase Kinase 3 Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 71. India Glycogen Synthase Kinase 3 Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 72. Australia Glycogen Synthase Kinase 3 Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 73. Australia Glycogen Synthase Kinase 3 Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Taiwan Glycogen Synthase Kinase 3 Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 75. Taiwan Glycogen Synthase Kinase 3 Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. Indonesia Glycogen Synthase Kinase 3 Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 77. Indonesia Glycogen Synthase Kinase 3 Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Thailand Glycogen Synthase Kinase 3 Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 79. Thailand Glycogen Synthase Kinase 3 Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 80. Malaysia Glycogen Synthase Kinase 3 Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 81. Malaysia Glycogen Synthase Kinase 3 Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 82. Philippines Glycogen Synthase Kinase 3 Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 83. Philippines Glycogen Synthase Kinase 3 Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 84. Vietnam Glycogen Synthase Kinase 3 Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 85. Vietnam Glycogen Synthase Kinase 3 Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 86. Asia Pacific Glycogen Synthase Kinase 3 Beta Market Share by Type in 2019
Figure 87. Asia Pacific Glycogen Synthase Kinase 3 Beta Market Share by Application in 2019
Figure 88. Latin America Glycogen Synthase Kinase 3 Beta Sales Growth Rate 2015-2020 (K Pcs)
Figure 89. Latin America Glycogen Synthase Kinase 3 Beta Revenue Growth Rate 2015-2020 (US$ Million)
Figure 90. Latin America Glycogen Synthase Kinase 3 Beta Sales Market Share by Country in 2019
Figure 91. Latin America Glycogen Synthase Kinase 3 Beta Revenue Market Share by Country in 2019
Figure 92. Mexico Glycogen Synthase Kinase 3 Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 93. Mexico Glycogen Synthase Kinase 3 Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 94. Brazil Glycogen Synthase Kinase 3 Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 95. Brazil Glycogen Synthase Kinase 3 Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 96. Argentina Glycogen Synthase Kinase 3 Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 97. Argentina Glycogen Synthase Kinase 3 Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 98. Latin America Glycogen Synthase Kinase 3 Beta Market Share by Type in 2019
Figure 99. Latin America Glycogen Synthase Kinase 3 Beta Market Share by Application in 2019
Figure 100. Middle East and Africa Glycogen Synthase Kinase 3 Beta Sales Growth Rate 2015-2020 (K Pcs)
Figure 101. Middle East and Africa Glycogen Synthase Kinase 3 Beta Revenue Growth Rate 2015-2020 (US$ Million)
Figure 102. Middle East and Africa Glycogen Synthase Kinase 3 Beta Sales Market Share by Country in 2019
Figure 103. Middle East and Africa Glycogen Synthase Kinase 3 Beta Revenue Market Share by Country in 2019
Figure 104. Turkey Glycogen Synthase Kinase 3 Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 105. Turkey Glycogen Synthase Kinase 3 Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 106. Saudi Arabia Glycogen Synthase Kinase 3 Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 107. Saudi Arabia Glycogen Synthase Kinase 3 Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 108. U.A.E Glycogen Synthase Kinase 3 Beta Sales Growth Rate (2015-2020) (K Pcs)
Figure 109. U.A.E Glycogen Synthase Kinase 3 Beta Revenue Growth Rate (2015-2020) (US$ Million)
Figure 110. Middle East and Africa Glycogen Synthase Kinase 3 Beta Market Share by Type in 2019
Figure 111. Middle East and Africa Glycogen Synthase Kinase 3 Beta Market Share by Application in 2019
Figure 112. North America Glycogen Synthase Kinase 3 Beta Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 113. North America Glycogen Synthase Kinase 3 Beta Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 114. Europe Glycogen Synthase Kinase 3 Beta Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 115. Europe Glycogen Synthase Kinase 3 Beta Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 116. Asia Pacific Glycogen Synthase Kinase 3 Beta Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 117. Asia Pacific Glycogen Synthase Kinase 3 Beta Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 118. Latin America Glycogen Synthase Kinase 3 Beta Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 119. Latin America Glycogen Synthase Kinase 3 Beta Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 120. Middle East and Africa Glycogen Synthase Kinase 3 Beta Sales Growth Rate Forecast (2021-2026) (K Pcs)
Figure 121. Middle East and Africa Glycogen Synthase Kinase 3 Beta Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 122. Porter's Five Forces Analysis
Figure 123. Channels of Distribution
Figure 124. Distributors Profiles
Figure 125. Bottom-up and Top-down Approaches for This Report
Figure 126. Data Triangulation
Figure 127. Key Executives Interviewed
核因子カッパBキナーゼサブユニットベータ阻害剤の世界市場（～2026年） Market Analysis and Insights: Global Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta Market The global Inhibitor of Nuclear Factor Kappa B Kinase Subunit Beta market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Inh…- RACベータセリン/スレオニンプロテインキナーゼの世界市場（～2026年） Market Analysis and Insights: Global RAC Beta Serine/Threonine Protein Kinase Market The global RAC Beta Serine/Threonine Protein Kinase market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global RAC Beta Serine/Threonine Protein…
- ホスファチジルイノシトール4,5ビスホスフェート3キナーゼ触媒サブユニットベータアイソフォームの世界市場（～2026年） Market Analysis and Insights: Global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform Market The global Phosphatidylinositol 4,5 Bisphosphate 3 Kinase Catalytic Subunit Beta Isoform market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at…
- 一酸化窒素シンターゼ脳の世界市場（～2026年） Market Analysis and Insights: Global Nitric Oxide Synthase Brain Market The global Nitric Oxide Synthase Brain market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Nitric Oxide Synthase Brain Scope and Market Size Nitric Ox…
- サイクリン依存性キナーゼ6の世界市場（～2026年） Market Analysis and Insights: Global Cyclin Dependent Kinase 6 Market The global Cyclin Dependent Kinase 6 market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Cyclin Dependent Kinase 6 Scope and Market Size Cyclin Dependen…